Gritstone Bio Inc (GRTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRTS | AMGN | BMY | VRTX | GILD |
| Company | Gritstone Bio Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.0403 | 258.00 | 56.85 | 391.00 | 90.40 |
| High | 0.0403 | 261.80 | 57.19 | 404.04 | 91.48 |
| Low | 0.0310 | 253.30 | 56.11 | 377.85 | 90.27 |
| Last | 0.0322 | 261.19 | 56.30 | 396.64 | 91.09 |
| Change | -0.0150 | +2.41 | -0.54 | -50.86 | +0.40 |
| % Change | -31.78% | +0.93% | -0.95% | -11.37% | +0.44% |
| Volume | 61,017,900 | 4,726,100 | 11,491,400 | 8,208,199 | 8,876,199 |
| 20-Day Average Volume | 52,407,121 | 4,654,110 | 9,774,450 | 1,586,165 | 6,668,755 |
| Previous Close | 0.0472 | 258.78 | 56.84 | 447.50 | 90.69 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2401 | 276.34 | 58.03 | 459.62 | 91.83 |
| 20-Day Raw Stochastic | 0.19% | 17.92% | 22.34% | 19.06% | 45.90% |
| 20-Day Relative Strength | 22.08% | 30.00% | 49.11% | 29.02% | 51.45% |
| Weighted Alpha | -80.76 | -15.53 | +15.03 | -11.44 | +22.53 |
| Today's Opinion | 100% Sell | 88% Sell | 80% Buy | 56% Sell | 88% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 80% Buy | 56% Sell | 88% Buy |
| Last Month's Opinion | 56% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -40.37% since 10/14/24 | -4.70% since 12/12/24 | +0.04% since 12/12/24 | -14.54% since 12/12/24 | -1.40% since 12/12/24 |
| Low | 0.0310 on 10/21/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 377.85 on 12/19/24 | 89.15 on 12/13/24 |
| High | 0.0840 on 10/15/24 | 274.07 on 12/13/24 | 58.54 on 12/18/24 | 474.18 on 12/17/24 | 93.59 on 12/17/24 |
| 1-Month | |||||
| %Chg | -94.87% since 09/20/24 | -6.70% since 11/19/24 | -3.31% since 11/19/24 | -11.47% since 11/19/24 | +3.81% since 11/19/24 |
| Low | 0.0310 on 10/21/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 377.85 on 12/19/24 | 87.77 on 11/20/24 |
| High | 0.6600 on 09/23/24 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 |
| 3-Month | |||||
| %Chg | -95.05% since 07/19/24 | -22.25% since 09/19/24 | +14.85% since 09/19/24 | -17.00% since 09/19/24 | +8.57% since 09/19/24 |
| Low | 0.0310 on 10/21/24 | 253.30 on 12/19/24 | 49.00 on 09/20/24 | 377.85 on 12/19/24 | 81.83 on 09/26/24 |
| High | 0.6946 on 07/23/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -95.63% since 04/19/24 | -14.64% since 06/18/24 | +37.96% since 06/18/24 | -15.12% since 06/18/24 | +44.24% since 06/18/24 |
| Low | 0.0310 on 10/21/24 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 377.85 on 12/19/24 | 64.86 on 06/20/24 |
| High | 1.0400 on 05/07/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,496 | 139,102,784 | 115,281,584 | 115,244,224 | 113,023,872 |
| Shares Outstanding, K | 108,569 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 16,340,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -138,490,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 920,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -23,400,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.49 | 0.55 | 0.45 | 0.36 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 08/13/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/13/24 | 02/04/25 | 02/06/25 | 02/03/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.84 | 49.27 | 0.00 | 20.95 |